Convergent Mechanisms Underlying Rapid Antidepressant Action.

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Traditional depression treatments have slow onset and low response rates.
• Ketamine demonstrates rapid antidepressant, anti-suicidal, and anti-anhedonic effects after single administration.

Purpose of the Study:

• To review proposed mechanisms of ketamine's antidepressant action.
• To discuss how these mechanisms inform the development of novel rapid-acting antidepressants.

Main Methods:

• Review of proposed molecular and cellular mechanisms of ketamine.
• Examination of downstream signaling pathways involved in ketamine's effects.
• Analysis of novel drug candidates targeting these pathways.

Main Results:

• Ketamine's actions involve N-methyl-D-aspartate receptor (NMDAR) modulation, GABAergic interneuron disinhibition, and hydroxynorketamine (HNK) metabolites.
• Downstream effects include mTOR activation, GSK3 and eEF2 deactivation, BDNF signaling enhancement, and AMPAR activation.
• Novel drug candidates targeting NMDARs, mGluR2/3, GABA receptors, and serotonin receptors are under investigation.

Conclusions:

• Ketamine's rapid antidepressant effects are mediated by complex interactions within neural circuits.
• Understanding these mechanisms facilitates the development of next-generation antidepressants with faster onset.
• Future depression treatment may involve rapid interventions within hours, not months.